The existing authors done an open-label pilot research that administered psilocybin to 15 therapy-resistant tobacco/nicotine-dependent smokers, while in the context of cognitive behavioral therapy for smoking cigarettes cessation [fifty eight]. Participants ended up administered ~0.29 mg/kg oral psi